Cytoprotective Peptides
BPC-157
C₆₂H₉₈N₁₆O₂₂
Key Research Findings
- Sikiric et al., multiple rodent assay reports — VEGF / NO pathway modulation.
- Published animal-model data on gastric mucosa cell-line assays.
- Stability profile documented in lyophilised storage at −20 °C.
Overview
BPC-157 is a synthetic pentadecapeptide derived from a sequence identified in human gastric juice. Supplied as a lyophilised powder for in-vitro research use only.
Mechanism of Action
Reported in published in-vitro and animal-model studies to interact with the VEGF and growth-hormone receptor pathways and to modulate nitric oxide synthesis. Not intended for human or veterinary use.
Research Effects
VEGF Pathway Activity
Extensive ResearchReported in published in-vitro assays as a modulator of vascular endothelial growth factor receptor expression.
Nitric Oxide Modulation
Moderate ResearchAnimal-model studies report modulation of nitric oxide synthesis pathways under controlled in-vitro conditions.
ERK1/2 Signalling
Moderate ResearchIn-vitro cell-line assays report effects on the ERK1/2 phosphorylation cascade.
Research Purposes Only — All information on this page is provided for scientific research purposes only. This product is not intended for human consumption, diagnosis, treatment, or prevention of any disease.
Quick Facts
Research Status Key
Featured in Bundles
BPC-157 is included in the following Zenterex research peptide bundles.
Related Peptides
Cytoprotective Peptides
TB-500
TB-500 is a synthetic analogue of the thymosin β4 (Tβ4) fragment. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
Copper & Collagen Peptides
GHK-Cu
GHK-Cu is a synthetic copper-tripeptide complex (Glycyl-L-Histidyl-L-Lysine bound to Cu²⁺). Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
Cytoprotective Peptides
KPV
KPV is a synthetic tripeptide fragment of the α-MSH C-terminal sequence. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →